{
  "title": "Special Episode, Part 2: Coronavirus - Building Models to Rebuild Economies",
  "description": "<p>When do we return to work? The market reaction? The drug pipeline? Chief Cross-Asset Strategist Andrew Sheets and Head Biotech Equity Analyst Matthew Harrison continue their discussion on the impact of the Covid-19 pandemic.</p>",
  "itunes:title": "Special Episode, Part 2: Coronavirus - Building Models to Rebuild Economies",
  "itunes:episodeType": "full",
  "itunes:episode": 146,
  "itunes:summary": "When do we return to work? The market reaction? The drug pipeline? Chief Cross-Asset Strategist Andrew Sheets and Head Biotech Equity Analyst Matthew Harrison continue their discussion on the impact of the Covid-19 pandemic.",
  "content:encoded": "<p>When do we return to work? The market reaction? The drug pipeline? Chief Cross-Asset Strategist Andrew Sheets and Head Biotech Equity Analyst Matthew Harrison continue their discussion on the impact of the Covid-19 pandemic.</p>",
  "guid": "gid://art19-episode-locator/V0/U5Xim_a4awrVAxoyJ4oHFAnYTPtZ6KcdjrOSyopEMsE",
  "pubDate": "Tue, 14 Apr 2020 16:21:52 -0000",
  "itunes:explicit": "no",
  "itunes:image": "",
  "itunes:duration": "00:10:23",
  "enclosure": ""
}